Clinical Trials Logo

Clinical Trial Summary

The objectives of this study are to compare the efficacy and safety of repeat doses of intravenous (IV) ferumoxytol with IV iron sucrose for the treatment of IDA in subjects with hemodialysis-dependent CKD.


Clinical Trial Description

This was a Phase IV, randomized, open-label, active-controlled, multicenter clinical trial designed to evaluate the safety, efficacy, and frequency of use of ferumoxytol compared to iron sucrose for the episodic treatment of IDA in hemodialysis subjects with CKD over a 1-year period. As part of this Main Study, an Oxidative Stress Substudy and an MRI Substudy were conducted. The Oxidative Stress Substudy, to be run concurrently with the initial TP of the Main Study, was to examine the varying degrees to which iron sucrose and ferumoxytol may or may not induce oxidative stress in vitro in subjects undergoing hemodialysis. The MRI Substudy, to be run concurrently with the Main Study and continue for an additional 11 months, was to assess the potential for deposition of iron in cardiac, hepatic, and pancreatic tissues and changes in laboratory parameters over a 2-year period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01227616
Study type Interventional
Source AMAG Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 4
Start date August 2013
Completion date February 2017

See also
  Status Clinical Trial Phase
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
Withdrawn NCT05073562 - Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia N/A
Completed NCT04631679 - Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)
Completed NCT05673161 - Retrospective Evaluation of the Effect of Iron (Fe) Infusion on Complications in Anemic Patients Undergoing Thoracotomy
Completed NCT04915820 - Iron and COVID-19 Vaccine Response N/A
Completed NCT04912661 - Iron and Vaccine Response N/A
Recruiting NCT04793906 - Meals to Improve Absorption of Iron Supplements N/A
Completed NCT05314062 - Effect of Iron Source on the Growth of Enteric Pathogens N/A
Recruiting NCT06238895 - Optimizing Dosing Strategies in Oral Iron Supplementation Phase 4
Completed NCT04705662 - GI Effects of Iron in Healthy Volunteers N/A
Completed NCT05762380 - Effect of Iron Supplements on the Growth of Enteric Pathogens N/A
Completed NCT04744181 - Patient Blood Management In CARdiac sUrgical patientS
Completed NCT04267653 - Lactoferrin Efficacy Versus Ferrous Sulfate in Treatment of Patients With Iron Deficiency Anemia Phase 4
Active, not recruiting NCT05545527 - Neuroimaging Ancillary Study
Terminated NCT03610230 - Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients N/A